Lung microbiome alterations in patients with anti-Jo1 antisynthetase syndrome and interstitial lung disease
AimTo characterize the lung microbiome in the bronchoalveolar lavage fluid (BALF) of patients with Antisynthetase Syndrome (ASSD) according to anti-Jo1 autoantibody positivity and evaluate the correlation with differential cell count and other bacterial genera in BALF.MethodsWe sequenced the 16S rib...
Main Authors: | Teresa Quintero-Puerta, Juan Alberto Lira-Lucio, Ramcés Falfán-Valencia, Ángel E. Vega-Sánchez, Eduardo Márquez-García, Mayra Mejía, Brandon Bautista-Becerril, Jorge Rojas-Serrano, Espiridión Ramos-Martínez, Ivette Buendía-Roldán, Gloria Pérez-Rubio |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-12-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2023.1321315/full |
Similar Items
-
Rituximab in the treatment of progressive interstitial lung disease associated with the antisynthetase syndrome
by: Javier Narváez, et al.
Published: (2024-06-01) -
Nonspecific interstitial pneumonia revealing an antisynthetase syndrome
by: Nedia Moussa, et al.
Published: (2022-11-01) -
Antisynthetase syndrome: An under-recognized cause of interstitial lung disease
by: Venkata Nagarjuna Maturu, et al.
Published: (2016-01-01) -
Antisynthetase syndrome presenting as interstitial lung disease: a case report
by: Aliena Badshah, et al.
Published: (2019-08-01) -
Clinical features, prognostic factors, and survival of patients with antisynthetase syndrome and interstitial lung disease
by: Na Zhao, et al.
Published: (2022-08-01)